Recombinant 2019-nCoV S-trimer Protein (501Y.V2, C-6His) DRA153
Specifications
| 50ug|500ug|1mg |
Alias:
2019-nCov S protein; 2019-nCoV Spike glycoprotein; 2019-nCoV S glycoprotein
Classification:
Immuno-Diagnostics Reagents
Product information:
Recombinant SARS-CoV-2 S-trimer Protein is produced by our Mammalian expression system and the target gene encoding Cys15-Gln1208 is expressed with a 6His tag at the C-terminus.L18F,D80A,D215G,L242-244delete,R246I,K417N,E484K,N501Y,D614G,A701V mutations were identified in the SARS-CoV-2 variant (known as 20C/501Y.V2 or B.1.351 lineage) which emerged in the United Kindom.
Species:
SARS-CoV-2
Isotype:
/
Conjugate tag:
C-6His
Source:
Human Cells
Formula:
Supplied as a 0.2 μm filtered solution of PBS,PH7.4
Molecular weight:
136.2kDa
Purity:
Animal ingredients:
None
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
ImmuSmol is specialized in developing antibodies directed against small molecules. Supported by public institutions including BPI, Conseil Régional Nouvelle Aquitaine, as well as by its Co-founder Associate – SCHIEVER, Immusmol is established in Bordeaux, France.